San Francisco, California, January 17, 20178: A recent market research report by TMR Research presents a thorough assessment of the global market for coronary stents. The report, titled “Coronary Stent Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” chiefly attributes the vast rise in the prevalence of a variety of cardiovascular diseases as the primary factor behind the healthy future growth prospects of the market.
The market has witnessed expansion at a promising pace in the past few years, in terms of the variety of products available, technological advancement, and demand across the globe. The market is also expected to witness a steady pace of expansion in the next few years owing to factors such as high incidence of coronary artery diseases worldwide, rising global geriatric population, increased demand for newer types of coronary stents, and sedentary lifestyles.
In terms of product type, the report segments the global coronary stents market into varieties such as bare-metal stents, drug-eluting stents, and bio-absorbable stents. Of these, the segment of bio-absorbable stents is expected to account for a dominant share in the market owing to their benefits over other varieties in terms of improved endothelial function, early restoration of vasomotion, and reduced risk of thrombosis and inflammation.
Geographically, the coronary stents market has been covered in the report for regions such as North America, Europe, and Asia Pacific, Latin America, and Middle East and Africa. Of these, the market in North America presently holds a dominant share in the overall market in terms of revenue contribution. This can be attributed to the presence of some of the leading medical device companies in the region, which gives the region the advantage of introducing innovative and advanced products earlier and gain early-bird benefit. The well-established healthcare industry and high prevalence of several cardiovascular conditions have also benefitted the North America coronary stents market gain strength in the recent years.
Europe accounts for a significant portion of the overall pie, followed by Asia Pacific. Europe also features a strong market owing to reasons mostly similar to North America, with the rising population of geriatrics being a key driver. The market in Asia Pacific is expected to dominate the global coronary stents market in the near future. This is attributed to growing incidences of several forms of CADs, unfulfilled healthcare needs of the population, rising awareness and affordability for advanced coronary stents, and higher penetration of Europe- and North America-based manufacturers for coronary stents in the region.
The research report on the global coronary stents market specifies the prominent players involved in developing and commercializing a variety of coronary stents also presents an overview of the recent developments in the market. The research report has provided an exhaustive list of the prominent players operating in the coronary stents market. It covers the leading players by providing a company overview, its product portfolio, and positioning in the global market. The comprehensive analysis helps new entrants formulate their entry strategy into this market and existing players formulate expansion strategies. The market players also gain valuable information about the most beneficial M&A strategies in the current market scenario as well.
Some of the leading companies involved in production, advancement, and commercialization of coronary stents are Meril Life Sciences Pvt. Ltd., Biotronik SE & Co. KG, Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, MicroPort Scientific Corporation, Biosensors International Group, Ltd., B. Braun Melsungen AG, Stentys SA, Translumina GmbH, and Vascular Concepts.
Get Sample Copy of this Report